List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 80 studies with search of: "Azacitidine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS;   AML;   Solid Tumors
Interventions: Drug: azacitidine;   Drug: azacitidine;   Drug: azacitidine;   Drug: azacitidine;   Drug: azacitidine;   Drug: azacitidine;   Drug: azacitidine
2 Recruiting Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Transplantation;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Drug: ATG (Thymoglobulin);   Drug: Azacitidine (Vidaza);   Procedure: Stem Cell Transplant;   Drug: Tacrolimus;   Drug: Methotrexate
3 Recruiting Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Azacitidine;   Drug: Azacitidine;   Drug: Azacitidine
4 Recruiting Randomized Allogeneic Azacitidine Study
Conditions: Leukemia;   AML;   MDS
Intervention: Drug: Azacitidine
5 Recruiting Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
Condition: Solid Tumors
Interventions: Drug: Azacitidine;   Drug: Valproic Acid;   Drug: Carboplatin
6 Recruiting 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Intervention: Drug: 5-Azacytidine
7 Active, not recruiting Azacytidine and Valproic Acid in Patients With Advanced Cancers
Condition: Advanced Cancers
Interventions: Drug: Azacitidine;   Drug: Valproic Acid
8 Terminated Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: Azacitidine;   Drug: Erythropoietin;   Drug: Azacitidine
9 Completed Azacytidine With Valproic Acid Versus Ara-C in AML/MDS Patients
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: 5-Azacytidine;   Drug: Ara-C;   Drug: Valproic Acid
10 Recruiting Safety, Pharmacokinetics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes and Acute Myelogenous Leukemia
Conditions: Myelogenous Leukemia, Acute;   Myelodysplastic Syndromes
Intervention: Drug: Azacitidine/Oral Azacitidine
11 Recruiting Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory AML or High Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Azacitidine;   Drug: Ara-C;   Drug: Azacitidine;   Drug: Ara-C
12 Terminated Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Interventions: Drug: Azacitidine;   Drug: MGCD0103;   Drug: MGCD0103
13 Terminated Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma
Interventions: Drug: Azacitidine;   Drug: Cisplatin
14 Recruiting Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Conditions: Acute Myeloid Leukemia;   Elderly
Intervention: Drug: Azacitidine
15 Active, not recruiting Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
Conditions: Myelodysplastic Syndrome;   Leukemia
Intervention: Drug: Azacitidine
16 Terminated MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-Cell Lymphoma or Mantle Cell Lymphoma)
Intervention: Drug: MGCD0103 and Azacitidine
17 Active, not recruiting Ph II Study of Azacitidine in Myelofibrosis
Condition: Myelofibrosis
Intervention: Drug: Azacitidine
18 Recruiting Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome (MDS) Who Are Candidates For Allogeneic Hematopoietic Cell Transplant
Condition: Leukemia
Interventions: Drug: 5-azacitidine;   Procedure: Allogeneic Hematopoietic cell transplantation
19 Recruiting Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Lymphoma;   Multiple Myeloma
Intervention: Drug: azacitidine
20 Recruiting AVIDA The Vidaza® (Azacitidine) Patient Registry
Condition: Myelodysplastic Syndromes
Intervention: Drug: Azacitidine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services